A phase II, multinational, multicentre, double blind, double dummy, randomised, 5-way cross-over, placebo and active controlled clinical study to test the non-inferiority of a single dose of CHF 1535 (fixed combination of beclomethasone dipropionate 100 µg plus formoterol fumarate 6 µg dry powder) via NEXT DPI 1 or 4 inhalations versus CHF 1535 (beclomethasone dipropionate 100 µg plus formoterol fumarate 6 microg) pMDI with HFA-134a propellant 1 or 4 puffs on FEV1 AUC0-12h in partly controlled adult asthmatic patients
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Beclometasone/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 04 Jul 2012 Additional trial locations (France and Italy) added as reported by European Clinical Trials Database record.
- 22 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Jun 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.